Latest news
New 2026 Hyperlipidemia Guideline Expand Treatment Eligibility from 41% to 55% of Adults - Epic ResearchEpic Research · Wed, 05 Aug 2026 17:21:28 GMTLipfendra® (enlicitide) to Reduce LDL-C in Adults With Hypercholesterolemia - Medical Professionals ReferenceMedical Professionals Reference · Mon, 03 Aug 2026 04:00:00 GMTFDA approves first oral PCSK9 inhibitor for adults with high cholesterol - Gulf Coast MediaGulf Coast Media · Fri, 31 Jul 2026 02:15:00 GMT